HEMISPHERE ENERGY CORP (HME.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:HME - CA4236301020 - Common Stock
2.13 CAD
-0.02 (-0.93%)
Taking everything into account, HME scores 7 out of 10 in our fundamental rating. HME was compared to 218 industry peers in the Oil, Gas & Consumable Fuels industry. HME gets an excellent profitability rating and is at the same time showing great financial health properties. HME may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make HME suitable for value investing!
1. Profitability
1.1 Basic Checks
HME had positive earnings in the past year.
In the past year HME had a positive cash flow from operations.
Of the past 5 years HME 4 years were profitable.
HME had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 26.87%, HME belongs to the best of the industry, outperforming 98.17% of the companies in the same industry.
Looking at the Return On Equity, with a value of 40.34%, HME belongs to the top of the industry, outperforming 99.08% of the companies in the same industry.
HME's Return On Invested Capital of 33.61% is amongst the best of the industry. HME outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HME is significantly above the industry average of 6.53%.
The last Return On Invested Capital (33.61%) for HME is well below the 3 year average (38.31%), which needs to be investigated, but indicates that HME had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 26.87% | ||
| ROE | 40.34% | ||
| ROIC | 33.61% |
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
1.3 Margins
HME has a better Profit Margin (31.38%) than 94.95% of its industry peers.
HME's Profit Margin has improved in the last couple of years.
HME has a better Operating Margin (43.33%) than 91.74% of its industry peers.
In the last couple of years the Operating Margin of HME has grown nicely.
HME's Gross Margin of 60.30% is fine compared to the rest of the industry. HME outperforms 77.98% of its industry peers.
HME's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 43.33% | ||
| PM (TTM) | 31.38% | ||
| GM | 60.3% |
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
2. Health
2.1 Basic Checks
HME has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for HME has been reduced compared to 1 year ago.
HME has more shares outstanding than it did 5 years ago.
HME has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 5.46 indicates that HME is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 5.46, HME belongs to the best of the industry, outperforming 85.32% of the companies in the same industry.
HME has a debt to FCF ratio of 0.08. This is a very positive value and a sign of high solvency as it would only need 0.08 years to pay back of all of its debts.
The Debt to FCF ratio of HME (0.08) is better than 96.79% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that HME is not too dependend on debt financing.
HME has a Debt to Equity ratio of 0.03. This is in the better half of the industry: HME outperforms 76.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.08 | ||
| Altman-Z | 5.46 |
ROIC/WACC4.3
WACC7.82%
2.3 Liquidity
HME has a Current Ratio of 1.62. This is a normal value and indicates that HME is financially healthy and should not expect problems in meeting its short term obligations.
HME's Current ratio of 1.62 is fine compared to the rest of the industry. HME outperforms 72.94% of its industry peers.
HME has a Quick Ratio of 1.62. This is a normal value and indicates that HME is financially healthy and should not expect problems in meeting its short term obligations.
HME has a Quick ratio of 1.62. This is in the better half of the industry: HME outperforms 75.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.62 |
3. Growth
3.1 Past
The earnings per share for HME have decreased by -9.09% in the last year.
Measured over the past years, HME shows a very strong growth in Earnings Per Share. The EPS has been growing by 80.04% on average per year.
Looking at the last year, HME shows a quite strong growth in Revenue. The Revenue has grown by 18.31% in the last year.
HME shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.97% yearly.
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
Revenue 1Y (TTM)18.31%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%
3.2 Future
Based on estimates for the next years, HME will show a very negative growth in Earnings Per Share. The EPS will decrease by -15.87% on average per year.
HME is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -7.01% yearly.
EPS Next Y-14.17%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
EPS Next 5Y-15.87%
Revenue Next Year-5.82%
Revenue Next 2Y-3.77%
Revenue Next 3Y-4.28%
Revenue Next 5Y-7.01%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 7.10, the valuation of HME can be described as very cheap.
HME's Price/Earnings ratio is rather cheap when compared to the industry. HME is cheaper than 90.37% of the companies in the same industry.
HME's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.49.
A Price/Forward Earnings ratio of 7.95 indicates a rather cheap valuation of HME.
HME's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HME is cheaper than 77.98% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of HME to the average of the S&P500 Index (23.69), we can say HME is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.1 | ||
| Fwd PE | 7.95 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HME is valued cheaper than 91.74% of the companies in the same industry.
95.87% of the companies in the same industry are more expensive than HME, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.98 | ||
| EV/EBITDA | 3.29 |
4.3 Compensation for Growth
HME has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as HME's earnings are expected to decrease with -9.18% in the coming years.
PEG (NY)N/A
PEG (5Y)0.09
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.65%, HME is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.83, HME pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.31, HME pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.65% |
5.2 History
HME has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
HME pays out 57.92% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP57.92%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
TSX-V:HME (12/5/2025, 7:00:00 PM)
2.13
-0.02 (-0.93%)
Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners0.79%
Inst Owner ChangeN/A
Ins Owners15.55%
Ins Owner ChangeN/A
Market Cap201.56M
Revenue(TTM)99.94M
Net Income(TTM)31.93M
Analysts84
Price Target2.47 (15.96%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.65% |
Yearly Dividend0.16
Dividend Growth(5Y)N/A
DP57.92%
Div Incr Years2
Div Non Decr Years2
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.06%
Min EPS beat(2)-2.91%
Max EPS beat(2)2.8%
EPS beat(4)1
Avg EPS beat(4)-2.76%
Min EPS beat(4)-8.02%
Max EPS beat(4)2.8%
EPS beat(8)3
Avg EPS beat(8)-3.68%
EPS beat(12)6
Avg EPS beat(12)3.66%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.19%
Min Revenue beat(2)4.39%
Max Revenue beat(2)5.99%
Revenue beat(4)3
Avg Revenue beat(4)2.23%
Min Revenue beat(4)-2.87%
Max Revenue beat(4)5.99%
Revenue beat(8)6
Avg Revenue beat(8)1.14%
Revenue beat(12)8
Avg Revenue beat(12)-0.62%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.59%
PT rev (3m)5.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-3.51%
EPS NY rev (3m)-5.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.32%
Revenue NY rev (1m)-1.77%
Revenue NY rev (3m)-2.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.1 | ||
| Fwd PE | 7.95 | ||
| P/S | 1.98 | ||
| P/FCF | 4.98 | ||
| P/OCF | 3.53 | ||
| P/B | 2.55 | ||
| P/tB | 2.55 | ||
| EV/EBITDA | 3.29 |
EPS(TTM)0.3
EY14.08%
EPS(NY)0.27
Fwd EY12.57%
FCF(TTM)0.43
FCFY20.08%
OCF(TTM)0.6
OCFY28.33%
SpS1.08
BVpS0.84
TBVpS0.84
PEG (NY)N/A
PEG (5Y)0.09
Graham Number2.38
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 26.87% | ||
| ROE | 40.34% | ||
| ROCE | 44.65% | ||
| ROIC | 33.61% | ||
| ROICexc | 43.9% | ||
| ROICexgc | 43.9% | ||
| OM | 43.33% | ||
| PM (TTM) | 31.38% | ||
| GM | 60.3% | ||
| FCFM | 39.77% |
ROA(3y)27.91%
ROA(5y)18.35%
ROE(3y)41.42%
ROE(5y)28.93%
ROIC(3y)38.31%
ROIC(5y)29.36%
ROICexc(3y)41.04%
ROICexc(5y)31.02%
ROICexgc(3y)41.04%
ROICexgc(5y)31.02%
ROCE(3y)50.88%
ROCE(5y)39%
ROICexgc growth 3Y12.92%
ROICexgc growth 5Y20.01%
ROICexc growth 3Y12.92%
ROICexc growth 5Y20.01%
OM growth 3Y2.1%
OM growth 5Y4.69%
PM growth 3Y34.16%
PM growth 5Y45.92%
GM growth 3Y-1.38%
GM growth 5Y-1.19%
F-Score5
Asset Turnover0.86
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.08 | ||
| Debt/EBITDA | 0.04 | ||
| Cap/Depr | 148.25% | ||
| Cap/Sales | 16.33% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 103.23% | ||
| Profit Quality | 126.75% | ||
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.62 | ||
| Altman-Z | 5.46 |
F-Score5
WACC7.82%
ROIC/WACC4.3
Cap/Depr(3y)210.69%
Cap/Depr(5y)187.35%
Cap/Sales(3y)20.24%
Cap/Sales(5y)19.51%
Profit Quality(3y)104.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.09%
EPS 3Y72.84%
EPS 5Y80.04%
EPS Q2Q%-22.22%
EPS Next Y-14.17%
EPS Next 2Y-9.92%
EPS Next 3Y-9.18%
EPS Next 5Y-15.87%
Revenue 1Y (TTM)18.31%
Revenue growth 3Y32.32%
Revenue growth 5Y25.97%
Sales Q2Q%-13.24%
Revenue Next Year-5.82%
Revenue Next 2Y-3.77%
Revenue Next 3Y-4.28%
Revenue Next 5Y-7.01%
EBIT growth 1Y-0.96%
EBIT growth 3Y35.09%
EBIT growth 5Y31.88%
EBIT Next Year34.08%
EBIT Next 3Y-0.98%
EBIT Next 5Y-5.77%
FCF growth 1Y70.97%
FCF growth 3Y57.01%
FCF growth 5YN/A
OCF growth 1Y41.47%
OCF growth 3Y36.33%
OCF growth 5Y34.82%
HEMISPHERE ENERGY CORP / HME.CA FAQ
What is the ChartMill fundamental rating of HEMISPHERE ENERGY CORP (HME.CA) stock?
ChartMill assigns a fundamental rating of 7 / 10 to HME.CA.
What is the valuation status of HEMISPHERE ENERGY CORP (HME.CA) stock?
ChartMill assigns a valuation rating of 8 / 10 to HEMISPHERE ENERGY CORP (HME.CA). This can be considered as Undervalued.
Can you provide the profitability details for HEMISPHERE ENERGY CORP?
HEMISPHERE ENERGY CORP (HME.CA) has a profitability rating of 9 / 10.
What is the earnings growth outlook for HEMISPHERE ENERGY CORP?
The Earnings per Share (EPS) of HEMISPHERE ENERGY CORP (HME.CA) is expected to decline by -14.17% in the next year.
How sustainable is the dividend of HEMISPHERE ENERGY CORP (HME.CA) stock?
The dividend rating of HEMISPHERE ENERGY CORP (HME.CA) is 5 / 10 and the dividend payout ratio is 57.92%.